Mitsui Chemicals Backs Materia Bioworks to Scale Sustainable Bioplastics

In August 2026, Mitsui Chemicals made a minority investment in Materia Bioworks through a corporate venture capital fund to accelerate sustainable bioplastic development. By combining Mitsui's biomass materials with Materia's AI-powered design platform, the partnership aims to slash production costs and time while expanding global eco-friendly material offerings.

Inside the AI Platform Fast-Tracking Next-Gen Sustainable Plastics

Mitsui Chemicals Inc. has made a minority investment in Toronto-based startup Materia Bioworks Inc. through its 321Catalyst corporate venture fund to enhance sustainable bioplastic development. Founded in November 2023, Materia Bioworks uses computational chemistry and AI for its Material Application Prediction System (MAPS), which designs and formulates sustainable materials, significantly reducing development time and costs. Hasitha de Alwis is the CEO of Materia Bioworks.

The MAPS platform features material design, manufacturing optimization, marketplace connections, and compliance support, allowing tailored bioplastics based on specific performance criteria. Manufacturing optimization features include digital twin simulations of customer production lines, offering advice on optimal processing conditions.

The platform also connects customers with verified bioplastic suppliers through a proprietary marketplace network and supports regulatory compliance leveraging a comprehensive database of biomaterials and biodegradable materials. This partnership will enable Mitsui Chemicals, led by CEO Satoshi Ichimura, to incorporate its biomass materials into Materia Bioworks' services, fostering collaboration on new bioplastic materials to satisfy customer demands.

Impact on the Chemicals and Materials Industry

This partnership positively impacts the industry by merging traditional biomass production with AI to predict formulations, bypassing costly trial-and-error research and development digitally. It scales eco-friendly plastics globally by reducing costs, shortening timelines, and streamlining regulatory compliance.

The partnership between Mitsui and Materia transforms the chemical industry by combining physical manufacturing with digital platforms. It accelerates research through AI simulations, improves factory efficiency with digital twins, links global supply networks, and speeds up eco-friendly regulatory approvals.

This collaboration brings major operational benefits. Faster R-D cycles replace lab tests with AI predictions. Production efficiency grows through simulated factory lines. Global supply integration brings heavy manufacturing with verified suppliers. Standardized compliance leverages built-in databases for fast regional approvals.

This helps to address industry limits by reducing prototyping costs with digital screening, fixing performance gaps by matching exact physical traits, speeding up time-to-market from years to months for zero-carbon goals, and easing complex international regulations through automated compliance databases.

Impact on the Bioplastics Industry

The global bioplastics market size is calculated at USD 23.81 billion in 2025 and is predicted to increase from USD 28.08 billion in 2026 to approximately USD 119.12 billion by 2035, expanding at a CAGR of 17.47% from 2026 to 2035.

According to Precedence Research, this partnership significantly impacts the industry by merging AI-driven material design with scaled chemical manufacturing. It addresses traditional sector limitations by digitalizing the entire lifecycle of sustainable polymer development.

This move supports the industry by replacing slow lab experiments with Materia Bioworks’s AI platform to advance time-to-market. This integrates Mitsui Chemicals’s established biomass material technologies with new software design services. It also offers targeted customization by formulating polymers matching exact mechanical, thermal, and physical standards required by commercial buyers.

This partnership contributes to addressing industry limitations by reducing high development costs with AI predictive modeling that lowers physical trials, bypassing manufacturing bottlenecks by leveraging digital twin simulations, easing supply chain fragmentation through a verified sustainable material marketplace, and clearing regulatory limitations through a global biomaterial compliance database to navigate complex international approval processes.

About Mitsui Chemicals, Inc.

Mitsui Chemicals, Inc. is a major global chemical company based in Tokyo, Japan. With nearly 20,000 workers, it supplies advanced materials and specialized solutions for the automotive, healthcare, packaging, and electronics fields across the world.

Under its VISION 2030 plan, the company aims to shift from commodity materials to high-margin, solution-driven operations. It focuses on solving global social challenges, achieving carbon neutrality, and advancing a circular economy through biomass-derived alternatives and recycling technologies.

About Materia Bioworks

Founded in 2023, Toronto-based Materia Bioworks offers an AI-driven platform and marketplace designed to help manufacturers transition from petroleum-based plastics to sustainable and bio-based alternatives. The company aims to facilitate a circular economy by reducing supply chain fragmentation and reducing research and development costs for consumer packaged goods brands.

Materia’s flagship software, MAPS, leverages AI and computational chemistry to simulate, test, and optimize biodegradable formulas by providing digital twin technology for manufacturing optimization. The company provides a two-sided B2B marketplace bridging manufacturers with verified suppliers, along with built-in regulatory compliance support.